Figure 1
From: Bench-to-bedside review: Candida infections in the intensive care unit
Mortality rates associated with Candida infections. Shown are rates of all-cause mortality from candidaemia or invasive candidiasis at (a) the end of antifungal therapy and (b) the end of follow up in recent randomized clinical trials. Numbers given in parenthesis on the x-axis indicate the reference numbers of the clinical trials. Duration of follow-up in panel a: 12 weeks, 22 to 4 weeks and 32 to 3 weeks. Duration of follow-up in panel b: 18 to 10 weeks and 212 to 14 weeks. AmB-d, amphotericin B-deoxycholate; Anidula, anidulafungin; Caspo, caspofungin; Flu, fluconazole; L-AmB, amphotericin B, liposomal preparation; Mica, micafungin; Vori, voriconazole.